EirGenix Inc. 6589.TWO Stock
EirGenix Inc. Price Chart
EirGenix Inc. 6589.TWO Financial and Trading Overview
EirGenix Inc. stock price | 82.6 TWD |
Previous Close | 108.5 TWD |
Open | 109 TWD |
Bid | 109.5 TWD x N/A |
Ask | 110 TWD x N/A |
Day's Range | 109 - 111 TWD |
52 Week Range | 78 - 163.5 TWD |
Volume | 1.09M TWD |
Avg. Volume | 3.37M TWD |
Market Cap | 33.34B TWD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3 TWD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 172 TWD |
6589.TWO Valuation Measures
Enterprise Value | 33.02B TWD |
Trailing P/E | N/A |
Forward P/E | 24.013159 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 3.1194804 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
EirGenix Inc. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 19.88% |
S&P500 52-Week Change | 20.43% |
52 Week High | 163.5 TWD |
52 Week Low | 78 TWD |
50-Day Moving Average | 113.86 TWD |
200-Day Moving Average | 117.11 TWD |
6589.TWO Share Statistics
Avg. Volume (3 month) | 3.37M TWD |
Avg. Daily Volume (10-Days) | 1.19M TWD |
Shares Outstanding | 304.49M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 33.39% |
% Held by Institutions | 14.93% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | 4.88 TWD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 756.45M TWD |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | -1.1 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 35.102 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of EirGenix Inc.
Country | Taiwan |
State | N/A |
City | New Taipei City |
Address | No. 101, Kangning Street |
ZIP | N/A |
Phone | 886 2 7708 0123 |
Website | https://www.eirgenix.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical, quality control, cGMP manufacturing mammalian system and microbial system, and antibody-drug conjugate services. It also provides covid-19 antigen rapid test and CRM197 carrier protein related products. The company was incorporated in 2012 and is based in New Taipei City, Taiwan.
Q&A For EirGenix Inc. Stock
What is a current 6589.TWO stock price?
EirGenix Inc. 6589.TWO stock price today per share is 82.6 TWD.
How to purchase EirGenix Inc. stock?
You can buy 6589.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EirGenix Inc.?
The stock symbol or ticker of EirGenix Inc. is 6589.TWO.
Which industry does the EirGenix Inc. company belong to?
The EirGenix Inc. industry is Biotechnology.
How many shares does EirGenix Inc. have in circulation?
The max supply of EirGenix Inc. shares is 306.05M.
What is EirGenix Inc. Price to Earnings Ratio (PE Ratio)?
EirGenix Inc. PE Ratio is now.
What was EirGenix Inc. earnings per share over the trailing 12 months (TTM)?
EirGenix Inc. EPS is -3 TWD over the trailing 12 months.
Which sector does the EirGenix Inc. company belong to?
The EirGenix Inc. sector is Healthcare.